🇺🇸 FDA
Patent

US 10869846

N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress

granted A61KA61K31/16A61K31/167

Quick answer

US patent 10869846 (N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress) held by SENTIENT LIFESCIENCES, INC. expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SENTIENT LIFESCIENCES, INC.
Grant date
Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/16, A61K31/167, A61K31/375, A61K9/0014